1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Infectious Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Infectious Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • March 2022
  • 112 pages
  • ID: 6249272
  • Format: PDF
  • Mordor Intelligence LLP


Table of Contents

Search Inside

The Infectious Disease Diagnostics Market was estimated to be USD 38,480.89 million in 2021 and is poised to grow at a CAGR of 3.79% by 2027 to reach USD 50,345.74 million.

The COVID-19 pandemic has significantly impacted the infectious disease diagnostics market. Increasing incidences of infection in COVID-19 patients is anticipated to have a positive impact on the market studied. For instance, according to World Health Organization, as of 24th February 2022, there were approximately 428,511,601 confirmed cases of COVID-19 infection across the world. Diagnostics for SARS-CoV-2 screening are being developed continuously to cater to the needs of markets with unique regulatory constraints. For example, in November 2021, Detect, a health technology firm, launched a new PCR-quality at-home Covid-19 quick molecular test to address testing needs at home, school, and work, in the United States. Likewise, CoviSwift, by Mylab Discovery Solutions, a point-of-care (POC) RT-PCR testing solution that may be utilized in small labs, in-hospital labs, airports, and communities, was approved and launched in February 2022. Similarly, Abbott introduced the RealTime SARS-CoV-2 assay, a PCR-based test for the diagnosis of COVID-19, in March 2020, and BioMedomics released a PoC COVID-19 test that can identify antibodies in blood within 15 minutes in March 2020. As a result, the demand for infectious disease diagnostic products is all set to increase with an increasing number of people suffering from coronavirus. In addition, several diagnostic laboratories and testing facilities are also being launched that are expanding the scope of growth for the market. For instance, in June 2020, the Union Minister of Health and Family Welfare launched India’s first mobile I-Lab (Infectious disease diagnostic lab) for COVID-19 testing. Such developments are anticipated to boost the demand for infectious disease diagnostic products in near future.

Further, the major factors fueling the market growth are the increasing prevalence of infectious diseases, the shift in focus from centralized laboratories to point-of-care testing, and increasing R&D activities on infectious disease diagnostics. Scientific research and development activities in developing novel technologies and techniques such as mass spectrometry and next-generation sequencing (NGS) are changing the way how rapid diagnostics are being performed to detect diseases that are contributing to the market growth. For instance, in April 2021, bioMérieux, a world leader in the field of in-vitro diagnostics, received the CE-marking for VITEK MS PRIME, the next generation of the VITEK MS MALDI-TOF1 mass spectrometry system for routine pathoden identification in minutes.

In addition, the growing inclination of end-users toward point-of-care testing is also anticipated to drive market growth. The point-of-care diagnostics provide rapid actionable information for patient care at the real-time and site of the disease encounter. Thus, various major players are focused on research and development activities to develop point-of-care diagnostics solutions for developing countries. The key companies are continuously evolving their product offering by launching new products or forming collaborations with others along with mergers and acquisitions which will also boost the growth of the studied market, globally. For instance, in July 2021, QuantuMDx launched the rapid polymerase chain reaction point-of-care diagnostic system called Q-POC for COVID-19.

However, inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques are the factors restraining the growth of the market.

Key Market Trends

Human Immunodeficiency Virus (HIV) Segment is Expected to Garner a Large Share of the Market

Based on application, the human immunodeficiency virus segment is anticipated to witness significant growth. According to the Minority of HIV/AIDS Fund (MHAF), United States Department of Health and Human Services Statistics updated in June 2021, there are approximately 37.6 million people, of which 35.9 million were adults and 1.7 million were children (less than 15 years old) across the globe with HIV in 2020. The same source also reports that an estimated 1.5 million individuals worldwide acquired HIV in 2020. This increasing burden of HIV creates demands for diagnosis and detection tests and thus leading to the growth of the market. Such a high prevalence of viral diseases is contributing to the increasing demand for diagnostic tests. Moreover, in August 2021, the Human Rights Campaign (HRC) Foundation, in partnership with "Us Helping Us"launched the United States’ first national in-home HIV testing program centered. Also, in June 2020, the DC Department of Health (District of Columbia Health) announced a new opportunity for DC residents to get free, at-home HIV test kits in recognition of National HIV Testing Day. Thus, owing to the high prevalence of this dreadful disease, the demand for early diagnostic tests is expected to increase as early diagnosis, thereby contributing to the market growth. Hence, this market is expected to increase in the future.

North America is Anticipated to Observe a Significant Growth in Infectious Disease Diagnostics Market

Within North America, the United States has held a major share of the market. The major factors contributing to the market growth are the increasing prevalence of infectious diseases and high expenditure on healthcare, and an increase in awareness among the population regarding the availability of treatment devices.

For instance, according to statistics published by MedAlertHelp, in 2022, stated that 5% to 20% of Americans are diagnosed with influenza every year. Further, according to the data published by the Centers for Disease Control and Prevention, in October 2021, overall, 35 million flu-related illnesses, 380,000 flu-related hospitalizations, 20,000 flu-related deaths, and 16 million flu-related medical visits were reported in the 2019-2020 season. This growing burden of diseases is anticipated to have a positive impact on market growth over the coming years.

In addition, in June 2021, RNA Disease Diagnostics, Inc., a company developing a best-in-class molecular diagnostics platform for infectious disease detection, revealed that the United States Food and Drug Administration (FDA) has registered the laboratory of Dipanjan Pan, MSc, Ph.D. at the University of Maryland School of Medicine (UMSOM), as an approved laboratory development site for RNADD’s Antisense COVID-19 molecular diagnostic test. Thus, in view of the factors mentioned above, the market is expected to witness significant growth in the region over the forecast period.

Competitive Landscape

The infectious disease diagnostics market is highly fragmented, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Danaher Corporation, Veracyte Inc, Abbott Laboratories, BioMérieux SA, F. Hoffmann-La Roche Ltd and Becton, Dickinson and Company.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Infectious Disease Diagnostics Market by Product, Test Type, Disease, Technology, End User - Global Forecast to 2027

  • $ 4950
  • June 2022
  • 287 pages

The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR.Market is driven by factors such as indication of infectious ...

  • World
  • APAC
  • Infectious Disease
  • Diagnostics
  • Industry analysis
  • Health Expenditure
  • Disposable Income


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on